Increased Factor VIII/vWf Levels in Patients with Reduced Platelet Number

Overview

Journal Blut

Specialty Hematology

Date 1987 May 1

PMID 3105627

Citations 3

Authors

A Casonato

F Fabris

M Boscaro

A Girolami

Affiliations

Soon will be listed here.

Abstract

Factor VIII/von Willebrand factor (VIII/vWf) related properties were studied in twenty six patients with thrombocytopenia. Fifteen patients were affected by idiopathic thrombocytopenic purpura (ITP) and 11 patients by thrombocytopenia of a different nature or non-ITP (n-ITP). All patients showed an enhancement of platelet associated IgG (PAIgG). A significant increase of factor VIII ristocetin cofactor (VIII R: RCoF) and factor VIII related antigen (VIII R:Ag) was found in ITP patients while normal values were observed for factor VIII coagulant (VIII:C). All factor VIII/vWf components, on the contrary, were increased in n-ITP group with a prevalence of VIII R:RCoF as observed in ITP group even though with lower mean values. Multimeric analysis of VIII/vWf demonstrated a higher concentration of all multimeric components, with major representation of higher molecular weight multimers (HMWM) in patients of both groups. Two patients were studied before and after improvement in platelet count. A decrease of vWf related properties (VIII R:RCoF and VIII R:Ag) concomitant with the increase in platelet count was found. In n-ITP patients a statistical correlation between VIII R:RCoF and PAIgG was also observed while no correlation was found between other factor VIII/vWf components and PAIgG both in ITP and n-ITP patients.

Citing Articles

Molecular Pathogenesis of Endotheliopathy and Endotheliopathic Syndromes, Leading to Inflammation and Microthrombosis, and Various Hemostatic Clinical Phenotypes Based on "Two-Activation Theory of the Endothelium" and "Two-Path Unifying Theory" of....

Chang J Medicina (Kaunas). 2022; 58(9).

PMID: 36143988 PMC: 9504959. DOI: 10.3390/medicina58091311.

Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".

Chang J Life (Basel). 2022; 12(2).

PMID: 35207507 PMC: 8874373. DOI: 10.3390/life12020220.

A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).

Araki R, Nishimura R, Kuroda R, Fujiki T, Mase S, Noguchi K Int J Hematol. 2018; 108(2):151-160.

PMID: 29663189 DOI: 10.1007/s12185-018-2454-y.

References

Ruggeri Z, De Marco L, Gatti L, Bader R, Montgomery R . Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983; 72(1):1-12. PMC: 1129155. DOI: 10.1172/jci110946. View

Gralnick H, Williams S, Morisato D . Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets. Blood. 1981; 58(2):387-97. View

Di Minno G, Shapiro S, Catalano P, De Marco L, Murphy S . The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets. Blood. 1983; 62(1):186-90. View

Fabris F, Casonato A, Grazia del Ben M, De Marco L, Girolami A . Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. Br J Haematol. 1986; 63(1):75-83. DOI: 10.1111/j.1365-2141.1986.tb07497.x. View

Nel J, Stevens K . A new method for the simultaneous quantitation of platelet-bound immunoglobuin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay (ELISA) procedure. Br J Haematol. 1980; 44(2):281-90. DOI: 10.1111/j.1365-2141.1980.tb01210.x. View

Sakariassen K, Bolhuis P, Sixma J . Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature. 1979; 279(5714):636-8. DOI: 10.1038/279636a0. View

De Marco L, Girolami A, ZIMMERMAN T, Ruggeri Z . von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest. 1986; 77(4):1272-7. PMC: 424474. DOI: 10.1172/JCI112430. View

Eche N, Sie P, Caranobe C, Nouvel C, Pris J, Boneu B . Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density. Scand J Haematol. 1981; 26(2):123-9. DOI: 10.1111/j.1600-0609.1981.tb01634.x. View

Coller B, Peerschke E, Scudder L, Sullivan C . Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983; 61(1):99-110. View

10.

Macfarlane D, Stibbe J, Kirby E, ZUCKER M, Grant R, McPherson J . Letter: A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh. 1975; 34(1):306-8. View

11.

HOYER L . The factor VIII complex: structure and function. Blood. 1981; 58(1):1-13. View

12.

Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z . Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood. 1984; 64(5):981-5. View

13.

Denson K . The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res. 1977; 10(1):107-19. DOI: 10.1016/0049-3848(77)90084-6. View

14.

Weiss H, Meyer D, Rabinowitz R, Pietu G, Girma J, Vicic W . Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med. 1982; 306(6):326-33. DOI: 10.1056/NEJM198202113060603. View

15.

De Marco L, Girolami A, Russell S, Ruggeri Z . Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest. 1985; 75(4):1198-203. PMC: 425445. DOI: 10.1172/JCI111816. View

16.

Lombardi R, Mannucci P, Seghatchian M, Garcia V, Coppola R . Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol. 1981; 49(1):61-8. DOI: 10.1111/j.1365-2141.1981.tb07197.x. View

17.

Ruggeri Z, Pareti F, Mannucci P, Ciavarella N, ZIMMERMAN T . Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med. 1980; 302(19):1047-51. DOI: 10.1056/NEJM198005083021902. View

18.

Fernandez M, Ginsberg M, Ruggeri Z, BATLLE F, ZIMMERMAN T . Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood. 1982; 60(5):1132-8. View

19.

Casonato A, Fabris F, Vicariotto M, Girolami A . The evaluation of factor VIII antigen by means of a simple slide test. Am J Clin Pathol. 1985; 84(1):107-11. DOI: 10.1093/ajcp/84.1.107. View

20.

Ruggeri Z, ZIMMERMAN T . The complex multimeric composition of factor VIII/von Willebrand factor. Blood. 1981; 57(6):1140-3. View